Radotinib Catalog No.:M10972-2 Clarithromycin prevents bacteria by acting

Clarithromycin prevents bacteria by acting as a protein synthesis inhibitor

but not in dogs

even when administered up to 48 hours after infection

Formula: C31H39N5O4S2

InChiKey: YKPUWZUDDOIDPM-SOFGYWHQSA-N

Radotinib Catalog No.:M10972-2 Clarithromycin prevents bacteria by actingRadotinib, also known as IY 5511, is an orally available, a second generation tyrosine kinase inhibitor of Bcr Abl fusion protein and the platelet derived growth factor receptor (PDGFR), with potential antineoplastic activity. Upon administration, radotinib specifically inhibits the Bcr Abl fusion protein, an abnormal enzyme expressed in Philadelphia chromosome positive chronic myeloid leukemia (CML) cells. In addition, this agent also inhibits PDGFR